EARLY ACCESS AGREEMENTEarly Access Agreement • August 12th, 2015 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
This exclusive Early Access Agreement (“Agreement”) is made and entered into the 3rd day of August, 2015, (“Effective Date”) by and between
Re: Agreement Between Armada Health Care, LLC and Hemispherx Biopharma, Inc.Agreement Between Armada Health Care, LLC and Hemispherx Biopharma, Inc. • August 12th, 2015 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
Armada Health Care would like to request an extension to the above mentioned contracts, initially signed on August 15, 2011 and extended in 2012, 2013 and 2014 subject to the same terms and conditions currently in place.
Sales, Marketing, Distribution, and Supply AgreementSales, Marketing, Distribution, and Supply Agreement • August 12th, 2015 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Delaware
WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. ("HEMISPHERX") and Emerge Health Pty Ltd. is a pharmaceutical company with its primary offices located at Suite 3, Level 1, 2 Theatre Place, Canterbury VIC 3126, Australia (" EMERGE”), each a “Party” together, “Parties” and
Re: Agreement Between BioRidge Pharma and Hemispherx Biopharma, Inc.Agreement Between Bioridge Pharma and Hemispherx Biopharma, Inc. • August 12th, 2015 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
BioRidge Pharma would like to request an extension to the above mentioned contracts, initially signed on August 15, 2011 and extended in 2012, 2013 and 2014 subject to the same terms and conditions currently in place.
